FERRERE

Associate

Mathías Rojas

Mathías Rojas is a member of the FERRERE Life Science team. He specializes in legal advice to companies in the pharmaceuticals industry, the food industry and pharmacy on regulatory aspects.

Mathías Rojas is a member of the FERRERE Life Science team. He specializes in legal advice to companies in the pharmaceuticals industry, the food industry and pharmacy on regulatory aspects.

His practice focuses primarily on advice for obtaining company authorizations and permits, as well as other procedures related to arranging representations, registry transfers, regulatory advice on new structures and regulatory changes. He counsels clients on product advertising and labeling, as well as on structuring strategies for claims and defenses of client interests vis-à-vis regulatory authorities.

He has also participated in successful requests for access to public information, including advice to clients throughout full proceedings, responses to opportunities to view files, and initiation of legal actions for access to public information.

He advises Van Dam S.A. (Arcor), Nestlé del Uruguay S.A., Coboe S.A. (Farmashop), Abbott Laboratories Uruguay S.A., Murry S.A. (Scienza), Sanofi-Aventis Uruguay S.A., AbbVie S.A., GlaxoSmithKline Uruguay S.A. and Bayer S.A., among others.

He has authored and coauthored publications, including texts on actions for protection, especially in relation to drugs and Human Rights issues. He has participated as speaker in academic seminars on Civil Law and on Human Rights.

  • Attorney, Universidad de Montevideo, 2019.
26/03/2020
Uruguay

Montevideo: new operating conditions for establishments open to the public

The Municipality of Montevideo, in resolution 1361/020, has established new operating conditions in order to avoid agglomerations of people and to minimize the risk of COVID-19 contagion.   

23/03/2020
Uruguay

How does COVID-19 affect the pharmaceutical industry in Uruguay?

The national as well as global health emergency caused by the novel coronavirus (COVID-19) is having a direct impact on different industries, and the pharmaceutical sector is not alien to this reality. 

21/03/2020
Uruguay

COVID-19: Government incorporates innovative telemedicine 3.0 solution for patient queries and tracking

The Government launched a pioneer telemedicine application developed with the collaboration of leaders in the software industry. Its aim is to decongest and facilitate access to medical attention for all persons who suspect they may have contracted the virus, while at the same time preventing possible contagion of health care workers.

20/02/2020
Uruguay

Data protection: relevant changes and new obligations

Decree approved by Council of Ministers regulates new personal data protection obligations with major changes.

View Folder